作者
Raymond G Booth, Nader H Moniri, Remko A Bakker, Neepa Y Choksi, William B Nix, Henk Timmerman, Rob Leurs
发表日期
2002/7/1
期刊
Journal of Pharmacology and Experimental Therapeutics
卷号
302
期号
1
页码范围
328-336
出版商
American Society for Pharmacology and Experimental Therapeutics
简介
Previously, (−)-trans-1-phenyl-3-N,N-dimethylamino-1,2,3,4-tetrahydronaphthalene ([−]-trans-H2-PAT) was shown to activate stereospecifically histamine H1 receptors coupled to modulation of tyrosine hydroxylase activity in guinea pig and rat forebrain in vitro and in vivo. Furthermore, the novel radioligand [3H](−)-trans-H2-PAT was shown to label selectively H1 receptors in guinea pig and rat brain with high affinity (K D, ∼0.1 and 0.5 nM, respectively) and a B max about 50 and 15%, respectively, of that observed for the H1antagonist radioligand [3H]mepyramine. In the current study, [3H](−)-trans-H2-PAT-labeled cloned guinea pig and human H1 receptors in Chinese hamster ovary (CHO) cell membranes with high affinity (K D, ∼0.08 and 0.23 nM, respectively) and a B max about 15% of that observed for [3H]mepyramine. The binding of H2-PAT to H1 receptors in both CHO-H1 cell lines was stereoselective with …
引用总数
20032004200520062007200820092010201120122013201420152016201720182019202020212022202316411114212111321
学术搜索中的文章
RG Booth, NH Moniri, RA Bakker, NY Choksi, WB Nix… - Journal of Pharmacology and Experimental …, 2002